Row:Years Ended
(In Millions, Except Per Share Amounts)
	Dec 29,
2018
	Dec 30,
2017
	Dec 31,
2016
Row:Net revenue 	$ 70,848 	$ 62,761 	$ 59,387
Row:Cost of sales 	27,111 	23,663 	23,154
Row:Gross margin 	43,737 	39,098 	36,233
Row:Research and development 	13,543 	13,035 	12,685
Row:Marketing, general and administrative 	6,750 	7,452 	8,377
Row:Restructuring and other charges 	(72) 	384 	1,744
Row:Amortization of acquisition-related intangibles 	200 	177 	294
Row:Operating expenses 	20,421 	21,048 	23,100
Row:Operating income 	23,316 	18,050 	13,133
Row:Gains (losses) on equity investments, net 	(125) 	2,651 	506
Row:Interest and other, net 	126 	(349) 	(703)
Row:Income before taxes 	23,317 	20,352 	12,936
Row:Provision for taxes 	2,264 	10,751 	2,620
Row:Net income 	$ 21,053 	$ 9,601 	$ 10,316
Row:Earnings per share—Basic 	$ 4.57 	$ 2.04 	$ 2.18
Row:Earnings per share—Diluted 	$ 4.48 	$ 1.99 	$ 2.12
Row:Weighted average shares of common stock outstanding:
			Row:Basic Diluted 	4,611 4,701 	4,701 4,835 	4,730
4,875
Row:(In Millions, Except Par Value)
	Dec 29,
2018
	Dec 30,
2017
Row:Assets
Current assets:
		Row:Cash and cash equivalents 	$ 3,019 	$ 3,433
Row:Short-term investments 	2,788 	1,814
Row:Trading assets 	5,843 	8,755
Row:Accounts receivable, net of allowance for doubtful accounts of $33 ($25 in 2017) 	6,722 	5,607
Row:Inventories 	7,253 	6,983
Row:Other current assets 	3,162 	2,908
Row:Total current assets 	28,787 	29,500
Row:Property, plant and equipment, net 	48,976 	41,109
Row:Equity investments 	6,042 	8,579
Row:Other long-term investments 	3,388 	3,712
Row:Goodwill 	24,513 	24,389
Row:Identified intangible assets, net 	11,836 	12,745
Row:Other long-term assets 	4,421 	3,215
Row:Total assets 	$ 127,963 	$ 123,249
Row:Liabilities, temporary equity, and stockholders’ equity
Current liabilities:
		Row:Short-term debt 	$ 1,261 	$ 1,776
Row:Accounts payable 	3,824 	2,928
Row:Accrued compensation and benefits 	3,622 	3,526
Row:Years Ended
(In Millions)
	Dec 29,
2018
	Dec 30,
2017
	Dec 31,
2016
Row:Cash and cash equivalents, beginning of period $ 	3,433 	$ 5,560 $ 	15,308
Row:Cash flows provided by (used for) operating activities:
			Row:Net income Adjustments to reconcile net income to net cash provided by operating
activities:
	21,053 	9,601 	10,316
Row:Depreciation Share-based compensation 	7,520 1,546 	6,752 1,358 	6,266
1,444
Row:Amortization of intangibles 	1,565 	1,377 	1,524
Row:(Gains) losses on equity investments, net 	155 	(2,583) 	(432)
Row:Loss on debt conversion and extinguishment (Gains) losses on divestitures 	260 (497) 	476 (387) 	—
—
Row:Deferred taxes 	(1,749) 	1,548 	257
Row:Changes in assets and liabilities:
			Row:Accounts receivable 	(1,714) 	(781) 	65
Row:Inventories 	(214) 	(1,300) 	119
Row:Accounts payable 	211 	191 	182
Row:Accrued compensation and benefits 	(260) 	311 	291
Row:Customer deposits and prepaid supply agreements 	1,367 	1,105 	—
Row:Income taxes payable and receivable 	148 	5,230 	1,382
Row:Other assets and liabilities 	41 	(788) 	394
Row:Total adjustments 	8,379 	12,509 	11,492
Row:Net cash provided by operating activities 	29,432 	22,110 	21,808
Row:Cash flows provided by (used for) investing activities:
Additions to property, plant and equipment 	(15,181) 	(11,778) 	(9,625)
Row:Acquisitions, net of cash acquired 	(190) 	(14,499) 	(15,470)
Row:Purchases of available-for-sale debt investments 	(3,843) 	(2,746) 	(9,269)
Row:Sales of available-for-sale debt investments 	195 	1,833 	2,847
Row:Maturities of available-for-sale debt investments 	2,968 	3,687 	5,654
Row:Purchases of trading assets 	(9,503) 	(13,700) 	(12,237)
Row:Maturities and sales of trading assets 	12,111 	13,970 	10,898
Row:Purchases of equity investments 	(874) 	(1,619) 	(963)
Row:Sales of equity investments 	2,802 	5,236 	1,080
Row:Proceeds from divestitures 	548 	3,124 	—
Row:Other investing Net cash used for investing activities 	(272) (11,239) 	730 (15,762) 	1,268
(25,817)
Row:Cash flows provided by (used for) financing activities:
			Row:Increase (decrease) in short-term debt, net Issuance of long-term debt, net of issuance costs 	460 423 	12 7,716 	(15)
2,734
Row:Repayment of debt and debt conversion 	(3,026) 	(8,080) 	(1,500)
Row:Proceeds from sales of common stock through employee equity incentive plans 	555 	770 	1,108
Row:Repurchase of common stock 	(10,730) 	(3,615) 	(2,587)
Row:Payment of dividends to stockholders 	(5,541) 	(5,072) 	(4,925)
Row:Other financing Net cash provided by (used for) financing activities 	(748) (18,607) 	(206) (8,475) 	(554)
(5,739)
Row:Net increase (decrease) in cash and cash equivalents 	(414) 	(2,127) 	(9,748)
Row:Cash and cash equivalents, end of period $ 	3,019 	$ 3,433 $ 	5,560
Row:Supplemental disclosures:
			Row:Acquisition of property, plant and equipment included in accounts payable and
accrued liabilities $ 	2,340 	$ 1,417 $ 	979
